Homogemcitabines
The invention relates to homogemcitabines of general formula (2), with the meanings for the substituents as given in claim 1 , method for production thereof, use for the production of the active agent gemcitabin and the use thereof for the production of medicaments for the treatment of proliferative...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | KARMIN SAADAT HERMANN KOLLMANN MUHAMED JASIC CHRISTIAN R. NOE |
| description | The invention relates to homogemcitabines of general formula (2), with the meanings for the substituents as given in claim 1 , method for production thereof, use for the production of the active agent gemcitabin and the use thereof for the production of medicaments for the treatment of proliferative diseases. The invention further relates to novel intermediates, as used in the inventive method. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2006272424A8</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2006272424A8</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2006272424A83</originalsourceid><addsrcrecordid>eNrjZBDwyM_NT0_NTc4sSUzKzEst5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8Y6hRgYGZkbmRiZGJo4WxsSpAgA6oCBN</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Homogemcitabines</title><source>esp@cenet</source><creator>KARMIN SAADAT ; HERMANN KOLLMANN ; MUHAMED JASIC ; CHRISTIAN R. NOE</creator><creatorcontrib>KARMIN SAADAT ; HERMANN KOLLMANN ; MUHAMED JASIC ; CHRISTIAN R. NOE</creatorcontrib><description>The invention relates to homogemcitabines of general formula (2), with the meanings for the substituents as given in claim 1 , method for production thereof, use for the production of the active agent gemcitabin and the use thereof for the production of medicaments for the treatment of proliferative diseases. The invention further relates to novel intermediates, as used in the inventive method.</description><language>eng</language><subject>CHEMISTRY ; DERIVATIVES THEREOF ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SUGARS</subject><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080529&DB=EPODOC&CC=AU&NR=2006272424A8$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080529&DB=EPODOC&CC=AU&NR=2006272424A8$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KARMIN SAADAT</creatorcontrib><creatorcontrib>HERMANN KOLLMANN</creatorcontrib><creatorcontrib>MUHAMED JASIC</creatorcontrib><creatorcontrib>CHRISTIAN R. NOE</creatorcontrib><title>Homogemcitabines</title><description>The invention relates to homogemcitabines of general formula (2), with the meanings for the substituents as given in claim 1 , method for production thereof, use for the production of the active agent gemcitabin and the use thereof for the production of medicaments for the treatment of proliferative diseases. The invention further relates to novel intermediates, as used in the inventive method.</description><subject>CHEMISTRY</subject><subject>DERIVATIVES THEREOF</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SUGARS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBDwyM_NT0_NTc4sSUzKzEst5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8Y6hRgYGZkbmRiZGJo4WxsSpAgA6oCBN</recordid><startdate>20080529</startdate><enddate>20080529</enddate><creator>KARMIN SAADAT</creator><creator>HERMANN KOLLMANN</creator><creator>MUHAMED JASIC</creator><creator>CHRISTIAN R. NOE</creator><scope>EVB</scope></search><sort><creationdate>20080529</creationdate><title>Homogemcitabines</title><author>KARMIN SAADAT ; HERMANN KOLLMANN ; MUHAMED JASIC ; CHRISTIAN R. NOE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2006272424A83</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2008</creationdate><topic>CHEMISTRY</topic><topic>DERIVATIVES THEREOF</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SUGARS</topic><toplevel>online_resources</toplevel><creatorcontrib>KARMIN SAADAT</creatorcontrib><creatorcontrib>HERMANN KOLLMANN</creatorcontrib><creatorcontrib>MUHAMED JASIC</creatorcontrib><creatorcontrib>CHRISTIAN R. NOE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KARMIN SAADAT</au><au>HERMANN KOLLMANN</au><au>MUHAMED JASIC</au><au>CHRISTIAN R. NOE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Homogemcitabines</title><date>2008-05-29</date><risdate>2008</risdate><abstract>The invention relates to homogemcitabines of general formula (2), with the meanings for the substituents as given in claim 1 , method for production thereof, use for the production of the active agent gemcitabin and the use thereof for the production of medicaments for the treatment of proliferative diseases. The invention further relates to novel intermediates, as used in the inventive method.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_AU2006272424A8 |
| source | esp@cenet |
| subjects | CHEMISTRY DERIVATIVES THEREOF HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SUGARS |
| title | Homogemcitabines |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T06%3A55%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KARMIN%20SAADAT&rft.date=2008-05-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2006272424A8%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |